Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage… EP News Bureau Oct 30, 2025 Phase IIa data show faster infection resolution and shorter hospital stays when AP-SA02 is added to standard antibiotic therapy,…
